1. Home
  2. MNSB vs CRDL Comparison

MNSB vs CRDL Comparison

Compare MNSB & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNSB
  • CRDL
  • Stock Information
  • Founded
  • MNSB 2003
  • CRDL 2017
  • Country
  • MNSB United States
  • CRDL Canada
  • Employees
  • MNSB N/A
  • CRDL N/A
  • Industry
  • MNSB Major Banks
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MNSB Finance
  • CRDL Health Care
  • Exchange
  • MNSB Nasdaq
  • CRDL Nasdaq
  • Market Cap
  • MNSB 124.2M
  • CRDL 102.0M
  • IPO Year
  • MNSB N/A
  • CRDL N/A
  • Fundamental
  • Price
  • MNSB $16.46
  • CRDL $1.01
  • Analyst Decision
  • MNSB
  • CRDL Strong Buy
  • Analyst Count
  • MNSB 0
  • CRDL 3
  • Target Price
  • MNSB N/A
  • CRDL $9.00
  • AVG Volume (30 Days)
  • MNSB 12.2K
  • CRDL 221.7K
  • Earning Date
  • MNSB 04-21-2025
  • CRDL 05-13-2025
  • Dividend Yield
  • MNSB 2.44%
  • CRDL N/A
  • EPS Growth
  • MNSB N/A
  • CRDL N/A
  • EPS
  • MNSB N/A
  • CRDL N/A
  • Revenue
  • MNSB $59,063,000.00
  • CRDL N/A
  • Revenue This Year
  • MNSB $18.73
  • CRDL N/A
  • Revenue Next Year
  • MNSB $9.60
  • CRDL N/A
  • P/E Ratio
  • MNSB N/A
  • CRDL N/A
  • Revenue Growth
  • MNSB N/A
  • CRDL N/A
  • 52 Week Low
  • MNSB $14.97
  • CRDL $0.77
  • 52 Week High
  • MNSB $20.88
  • CRDL $3.12
  • Technical
  • Relative Strength Index (RSI)
  • MNSB 52.77
  • CRDL 49.79
  • Support Level
  • MNSB $15.11
  • CRDL $0.77
  • Resistance Level
  • MNSB $16.30
  • CRDL $1.10
  • Average True Range (ATR)
  • MNSB 0.55
  • CRDL 0.10
  • MACD
  • MNSB -0.03
  • CRDL 0.02
  • Stochastic Oscillator
  • MNSB 73.00
  • CRDL 72.64

About MNSB MainStreet Bancshares Inc.

MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: